The study investigated the effects of the botanical Ageratum Conyzoides on its potential to increase hair growth and decrease hair loss
Gencor has announced the publication of its recent clinical trial backing its ingredient HairAGE as an oral supplement for improved hair health for men and women.
The study, published in the Trichology and Cosmetology Journal, investigated the effects of the botanical Ageratum Conyzoides, commonly known as billy goat weed, on its potential to increase hair growth and decrease hair loss.
The randomised, double-blind, placebo-controlled trial included 84 healthy women and men experiencing hair loss. Study participants took daily supplementation of 250mg of HairAGE or the placebo over 12 weeks. The results demonstrated a significant reduction in the appearance of hairline recession compared to the placebo group, and a substantial decrease in total prostaglandins (a group of lipids that control processes including inflammation) in the active group compared to placebo, further validating the earlier in-vitro mechanism of action, and suggesting a balanced inflammatory response for improved hair health.
HairAGE can now effectively be incorporated as an oral dietary supplement for improved hair health
- R.V. Venkatesh, co-founder at Gencor
Additionally, the male participants experienced a statistically significant reducation in the change from baseline in type-2 5a-reductase – known to influence hair loss and thinness – with a decrease from baseline in the HairAGE group and an increase in the placebo group. This again validates the action of inhibition of 5-Alpha Reductase, as seen in its earlier in-vitro study.
“This clinical trial supports the mechanism of action as well as showing hair recession consistent with what we have seen in the in-vitro, open-label, and double-blind topical studies with HairAGE,” R.V. Venkatesh, co-founder at Gencor. “According to this research, HairAGE can now effectively be incorporated as an oral dietary supplement for improved hair health, giving more flexibility in applications for women and men.”
To review the clinical data and for more information about HairAGE, visit GencorPacific.com.